Attitudes of Wisconsin pediatricians toward influenza immunization

WMJ. 2011 Apr;110(2):63-7.

Abstract

Objective: Determine the influenza immunization practices of Wisconsin pediatricians in response to evolving influenza prevention strategy in the United States.

Design: Two hundred fifty members of the Wisconsin Chapter of the American Academy of Pediatrics were surveyed prior to the 2004-2005 influenza season about their expectations for implementing the latest and future influenza vaccination recommendations for children and their use of trivalent inactivated influenza vaccines free of thimerosal as a preservative.

Results: Ninety-two percent of respondents expected to vaccinate most medically high-risk children against influenza, but only 53% would recommend influenza vaccine for most of their household contacts. Although 57% planned to vaccinate most healthy children ages 6 months to 23 months, just 27% thought the majority of household contacts of healthy infants under 23 months of age would be vaccinated. Fewer than 24% favored universal influenza vaccination for the majority of healthy school-aged children. Seventy percent had little or no concern about recommending thimerosal-containing influenza vaccines, but 60% agreed or strongly agreed thimerosal-free vaccine availability would increase parental acceptance of vaccinating their children.

Conclusion: Although Wisconsin pediatricians are aware of the importance of preventing influenza disease in children, barriers to universal influenza vaccination of children and key household contacts remain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Attitude of Health Personnel*
  • Chi-Square Distribution
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Influenza Vaccines*
  • Influenza, Human / prevention & control*
  • Pediatrics / standards*
  • Physicians / psychology*
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Statistics, Nonparametric
  • Surveys and Questionnaires

Substances

  • Influenza Vaccines